Mitsui Chemicals, Inc.
Overview of 2Q FY2026 (Interim) Financial Results and FY2026 Earnings Forecast
In the FY2026 second quarter summary, core operating profit increased year-over-year. Expansion in sales volumes in growth areas, foreign exchange gains from a weaker yen, and inventory valuation gains contributed to a company-wide core operating profit increase of 54.8 billion yen, leading to an upward revision of the full-year outlook to 150 billion yen. The consolidation impact from the acquisition of Ultradent Products, Inc. expanded consolidated results. Earnings forecasts from FY2024 onward were also revised upward.
Key Figures
- Revenue: 9,791 (YoY +1,655)
- Core Operating Profit: 993 (YoY +548)
- Exchange Rate: 159 yen/US$ (YoY +13)
- Domestic Naphtha Price: 108,350 yen/KL (YoY +43,450)
AI要約
Overview of Financial Results
In the FY2026 second quarter, company-wide core operating profit increased significantly year-over-year. Contributions included expanded sales volumes in growth areas, foreign exchange gains due to a weaker yen, and structural improvements in the B&GM area. Although Middle East developments had some impact, inventory valuation gains and one-off effects from naphtha price surges also contributed positively. Synergies from the acquisition of UPI (Ultradent Products, Inc.) also had a contributory effect. The full-year core operating profit forecast has been revised upward to 150 billion yen. Consolidation effects from the acquisition of Ultradent Products, Inc. were also reflected.
Outlook and Risks
For the second half, growth in core areas is expected to continue; however, risks include developments in the Middle East, raw material price trends, foreign exchange fluctuations, and one-time costs related to UPI, which may affect results. By segment, contributions from growth areas such as Life & Healthcare Solutions and ICT Solutions are expected to continue.
Mitsui Chemicals, Inc.
Company overview · Stock price · Financial data · All IR
